# Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia

> **NCT01051154** · PHASE2 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 72 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Malnutrition

## Interventions

- **DIETARY_SUPPLEMENT:** Docosahexaenoic acid (DHA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01051154
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051154, "Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01051154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*